Scholars@Duke publication: Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML)

Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML)

Publication , Conference

Erba, HP; Rizzieri, DA; O'Donnell, MR; Lundberg, AS; Ajami, AM; Rampersad, AD; Capizzi, RL

Published in: JOURNAL OF CLINICAL ONCOLOGY

June 20, 2007

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY

APA

Chicago

ICMJE

MLA

NLM

Erba, H. P., Rizzieri, D. A., O’Donnell, M. R., Lundberg, A. S., Ajami, A. M., Rampersad, A. D., & Capizzi, R. L. (2007). Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.

Erba, H. P., D. A. Rizzieri, M. R. O’Donnell, A. S. Lundberg, A. M. Ajami, A. D. Rampersad, and R. L. Capizzi. “Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Erba HP, Rizzieri DA, O’Donnell MR, Lundberg AS, Ajami AM, Rampersad AD, et al. Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML). In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Erba, H. P., et al. “Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML).” JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 18, AMER SOC CLINICAL ONCOLOGY, 2007.

Erba HP, Rizzieri DA, O’Donnell MR, Lundberg AS, Ajami AM, Rampersad AD, Capizzi RL. Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY